Jazz Pharmaceuticals plc logo JAZZ - Jazz Pharmaceuticals plc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 43
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $255.25 DETAILS
HIGH: $307.00
LOW: $229.00
MEDIAN: $242.00
CONSENSUS: $255.25
UPSIDE: 6.43%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue
Revenue 4,267.6 4,068.9 3,834.2 3,659.4 3,094.2 2,363.6 2,161.8 1,890.9 1,618.7 1,488.0 1,324.8 1,172.9 872.4 586.0 272.3 173.8 128.4 67.5 65.3 44.9 21.4 0
Cost of Revenue 503.3 445.7 435.6 540.5 440.8 148.9 127.9 121.5 110.2 105.4 102.5 117.4 102.1 78.4 13.9 13.6 9.6 13.9 8.9 7.0 4.3 0
Gross Profit 3,764.3 3,623.2 3,398.6 3,118.9 2,653.5 2,214.7 2,033.8 1,769.4 1,508.5 1,382.6 1,222.3 1,055.5 770.3 507.6 258.3 160.2 118.8 53.6 56.4 37.9 17.1 0
Operating Expenses
R&D Expenses 782.7 884 849.7 590.5 505.7 335.4 299.7 226.6 198.4 162.3 135.3 85.2 46.6 20.5 14.1 25.6 36.6 70.0 69.8 55.0 45.8 0
SG&A Expenses 1,809.3 1,385.3 1,343.1 1,417.0 1,451.7 854.2 736.9 683.5 544.2 502.9 449.1 406.1 304.3 223.9 108.9 69.0 58.7 111.4 78.5 51.4 23.6 0
Other Expenses 947.9 637.3 627.3 1,177.0 525.8 647.0 464.8 244.4 237.1 125.7 129.7 368.6 84.0 65.4 7.4 7.8 7.7 42.6 46.8 9.6 26.3 (24.8)
Operating Expenses 3,539.9 2,906.6 2,820.0 3,184.4 2,483.2 1,836.6 1,501.5 1,154.5 979.7 790.9 714.1 859.9 430.0 309.7 130.5 102.4 102.9 224.0 195.2 115.9 95.6 (24.8)
Operating Income
Operating Income 224.4 716.6 578.6 (65.5) 170.3 378.1 532.4 614.8 528.8 591.7 508.2 195.6 340.3 197.8 127.8 57.8 15.9 (170.4) (138.8) (78.1) (78.4) (24.8)
Interest Expense 195.1 238.1 289.4 288.2 278.8 99.7 72.3 78.5 77.8 61.9 56.9 52.7 26.9 16.9 1.7 12.7 22.8 19.7 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.0 0.0 1.8 0 0 0 0
Profitability
EBITDA 108.5 1,521.7 1,449.4 1,468.6 1,027.7 1,043.7 1,012.5 932.7 779.0 753.9 666.0 583.7 454.1 310.2 134.4 54.2 25.0 (125.6) (128.3) (67.7) (51.7) (24.8)
EBIT (433.5) 861.6 810.7 839.1 475.3 765.5 642.3 715.9 613.8 640.1 557.9 450.0 372.0 235.9 126.6 45.5 15.9 (140.6) (138.8) (78.1) (57.1) (24.8)
Income Before Tax (628.6) 468.7 294.9 (382.7) (113.6) 272.1 450.2 527.3 440.1 532.1 435.9 151.6 307.9 177.4 125.0 32.8 (6.8) (184.3) (138.8) (59.4) (85.2) (24.8)
Income Tax Expense (272.4) (91.4) (119.9) (158.6) 216.1 33.5 (73.2) 80.2 (47.7) 135.2 106.4 94.2 91.6 (83.8) 0 0 0 0 0.0 (18.7) 28.0 24.8
Net Income (356.1) 560.1 414.8 (224.1) (329.0) 238.6 523.4 447.1 487.8 396.8 329.5 58.4 216.3 288.6 125.0 32.8 (6.8) (184.3) (138.8) (59.4) (85.2) (24.8)
Per Share Data
EPS (Basic) -5.84 9.06 6.55 -3.58 -5.51 4.28 9.22 7.45 8.13 6.56 5.38 0.98 3.71 5.09 3.01 0.90 -0.23 -7.19 -10.04 -4.41 -6.32 -1.84
EPS (Diluted) -5.84 8.65 6.10 -3.58 -5.51 4.22 9.09 7.30 7.96 6.41 5.23 0.93 3.51 4.79 2.67 0.83 -0.23 -7.19 -10.04 -4.41 -6.32 -1.84
Shares Outstanding 61.0 61.8 63.3 62.5 59.7 55.7 56.7 60.0 60.0 60.5 61.2 59.7 58.3 56.6 41.5 36.3 30.0 25.6 13.8 13.5 13.5 13.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 1,391.9 2,412.9 1,506.3 881.5 591.4 1,057.8 637.3 309.6 386.0 366.0 15.6 24.9
Short-Term Investments 1,050 580 120 0 0 1,075 440 515 215 60 0 1.0
Net Receivables 830.7 716.8 705.8 651.5 563.4 396.5 356.0 263.8 224.1 234.2 12.3 6.6
Inventory 417.0 480.4 597.0 714.1 1,072.7 95.4 78.6 53.0 43.2 34.1 3.4 4.8
Other Current Assets 476.4 261.5 320.8 267.2 252.4 152.5 78.9 67.6 76.7 29.3 4.0 4.8
Total Current Assets 4,166.0 4,629.0 3,435.4 2,606.1 2,611.3 2,839.6 1,630.3 1,234.0 968.3 748.1 37.0 44.0
Non-Current Assets
Property, Plant & Equipment 258.7 227.0 235.0 301.4 343.4 257.1 270.9 200.4 170.1 107.5 1.1 2.5
Goodwill 1,829.3 1,716.3 1,753.1 1,692.7 1,827.6 958.3 920.0 927.6 947.5 893.8 38.2 38.2
Intangible Assets 4,429.5 4,755.7 5,418.0 5,794.4 7,152.3 2,195.1 2,441.0 2,731.3 2,979.1 3,012.0 29.9 32.5
Long-Term Investments 0 4.3 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 106.6 119.6 73.9 64.4 52.8 31.0 55.3 52.3 24.1 23.8 1.2 0.2
Total Non-Current Assets 7,493.3 7,383.2 7,957.9 8,229.1 9,687.3 3,696.3 3,908.6 3,969.5 4,155.4 4,052.2 70.4 73.5
Total Assets 11,659.3 12,012.3 11,393.4 10,835.3 12,298.6 6,535.9 5,538.9 5,203.5 5,123.7 4,800.2 107.4 117.5
Current Liabilities
Account Payables 122.1 77.9 102.8 90.8 100.3 26.9 47.5 40.6 24.4 22.4 2.2 5.7
Short-Term Debt 1,029.9 31 605.0 31 31 246.3 33.4 33.4 40.6 36.1 33.2 122.4
Deferred Revenue 0 0 0 0.5 2.1 2.5 4.7 5.4 8.6 1.1 2.7 12.3
Other Current Liabilities 1,019.5 189.8 142.3 169.4 193.1 124.6 85.0 62.5 64.0 47.7 3.0 16.5
Total Current Liabilities 2,242.5 1,038.6 1,536.7 933.2 809.3 653.7 364.5 345.5 293.9 257.4 59.2 173.5
Non-Current Liabilities
Long-Term Debt 4,328.4 6,077.6 5,108.0 5,693.3 6,018.9 1,848.5 1,573.9 1,563.0 1,540.4 1,993.5 91.1 0
Deferred Tax Liabilities 594.5 676.7 847.7 944.3 1,300.5 130.4 224.1 309.1 383.5 556.7 0 0
Other Non-Current Liabilities 124.5 86.6 104.8 106.8 117.0 101.1 109.4 218.9 176.6 112.6 19.7 25.6
Total Non-Current Liabilities 5,098.2 6,879.9 6,119.7 6,816.3 7,524.1 2,222.4 2,063.4 2,100.6 2,116.6 2,665.5 121.0 36.9
Total Liabilities 7,340.8 7,918.5 7,656.4 7,749.5 8,333.4 2,876.2 2,427.9 2,446.1 2,410.6 2,922.9 180.2 210.4
Stockholders' Equity
Common Stock 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Retained Earnings 646.2 1,127.3 878.7 733.6 830.2 1,159.9 1,067.8 841.0 918.0 528.9 (507.6) (500.8)
Accumulated Other Comprehensive Income (568.6) (947.7) (842.1) (1,125.5) (400.4) (134.4) (223.4) (197.8) (140.9) (317.3) 0 0.0
Total Stockholders' Equity 4,318.6 4,093.8 3,737.0 3,085.7 3,965.2 3,659.7 3,111.0 2,757.4 2,713.1 1,877.3 (72.8) (92.9)
Total Liabilities & Equity 11,659.3 12,012.3 11,393.4 10,835.3 12,298.6 6,535.9 5,538.9 5,203.5 5,123.7 4,800.2 107.4 117.5
Debt Metrics
Total Debt 5,423.9 6,162.4 5,791.6 5,812.1 6,152.9 2,249.3 1,771.2 1,596.4 1,581.0 2,029.6 124.3 122.4
Net Debt 4,032.0 3,749.5 4,285.3 4,930.6 5,561.5 1,191.6 1,133.9 1,286.8 1,195.0 1,663.7 108.7 97.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005
Operating Activities
Net Income (356.1) 560.1 414.8 (224.1) (329.7) 238.6 523.4 447.1 487.8 396.8 (85.2)
Depreciation & Amortization 696.3 660.1 638.7 629.5 552.5 278.3 370.2 216.7 165.2 113.8 5.4
Stock-Based Compensation 291.1 248.0 226.8 222.0 189.0 121.0 110.6 102.4 106.9 98.8 0
Change in Working Capital 18.9 (76.7) (204.4) 9.9 (48.0) (85.4) (150.1) 23.3 26.8 (22.7) 2.8
Other Non-Cash Items 1,150.6 212.7 276.3 926.9 345.4 484.2 159.0 98.2 132.0 45.0 24.7
Operating Cash Flow 1,355.8 1,395.9 1,092.0 1,272.0 778.5 899.6 776.4 798.9 693.1 590.5 (52.2)
Investing Activities
Capital Expenditure (58.8) (48.1) (24.0) (498.2) (45.5) (379.3) (182.3) (131.5) (114.0) (181.6) (1.4)
Acquisitions (858.1) 0 0 53 (6,234.8) (364.2) (142.2) 111.1 85 (1,502.4) (146.1)
Purchases of Investments 0 (1,305.1) (390.1) (61.0) (26.8) (2,397.7) (917.1) (1,165.9) (385) (65.3) 0
Sales/Maturities of Investments 1,360 845 270 60 1,095 1,755 985 855 230 173.8 6.0
Other Investing Activities (1,953.1) (10) (19) 0 (17.9) 378.5 101.3 (63.2) (85) (173.8) (12.2)
Investing Cash Flow (1,509.9) (508.2) (163.1) (446.2) (5,212.1) (1,007.7) (155.3) (394.5) (268.9) (1,749.3) (153.8)
Financing Activities
Net Debt Issuance (781) 374.8 (31) (582.0) 3,870.9 591.8 (33.4) (25.7) (326.7) 816.3 0
Stock Repurchased (125.0) (311.4) (269.8) (0.1) 0 (146.5) (301.4) (523.7) (98.8) (278.3) 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (75.2) (42.8) (4.5) (45.4) 99.7 99.7 (16.7) (23.1) 16.4 24.2 15
Financing Cash Flow (873.4) 20.5 (305.3) (529.5) 3,970.5 528.1 (293.7) (479.1) (409.1) 541.0 192.9
Cash Position
Net Change in Cash (1,021.0) 906.6 624.8 290.0 (466.3) 420.4 327.7 (76.4) 20.1 (622.8) (13.1)
Cash at Beginning 2,412.9 1,506.3 881.5 591.4 1,057.8 637.3 309.6 386.0 366.0 988.8 33.7
Cash at End 1,391.9 2,412.9 1,506.3 881.5 591.4 1,057.8 637.3 309.6 386.0 366.0 20.6
Free Cash Flow 1,297.0 1,347.8 1,068.0 773.8 733.0 520.4 594.1 667.4 579.1 409.0 (53.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Income Statement
Revenue 4,267.6 4,068.9 3,834.2 3,659.4 3,094.2 2,363.6 2,161.8 1,890.9 1,618.7 1,488.0 1,324.8 1,172.9 872.4 586.0 272.3 173.8 128.4 67.5 65.3 44.9 21.4 0
Gross Profit 3,764.3 3,623.2 3,398.6 3,118.9 2,653.5 2,214.7 2,033.8 1,769.4 1,508.5 1,382.6 1,222.3 1,055.5 770.3 507.6 258.3 160.2 118.8 53.6 56.4 37.9 17.1 0
Operating Income 224.4 716.6 578.6 (65.5) 170.3 378.1 532.4 614.8 528.8 591.7 508.2 195.6 340.3 197.8 127.8 57.8 15.9 (170.4) (138.8) (78.1) (78.4) (24.8)
Net Income (356.1) 560.1 414.8 (224.1) (329.0) 238.6 523.4 447.1 487.8 396.8 329.5 58.4 216.3 288.6 125.0 32.8 (6.8) (184.3) (138.8) (59.4) (85.2) (24.8)
EPS (Diluted) -5.84 8.65 6.10 -3.58 -5.51 4.22 9.09 7.30 7.96 6.41 5.23 0.93 3.51 4.79 2.67 0.83 -0.23 -7.19 -10.04 -4.41 -6.32 -1.84
Balance Sheet
Cash & Equivalents 1,391.9 2,412.9 1,506.3 881.5 591.4 1,057.8 637.3 309.6 386.0 366.0 15.6 24.9
Total Assets 11,659.3 12,012.3 11,393.4 10,835.3 12,298.6 6,535.9 5,538.9 5,203.5 5,123.7 4,800.2 107.4 117.5
Total Debt 5,423.9 6,162.4 5,791.6 5,812.1 6,152.9 2,249.3 1,771.2 1,596.4 1,581.0 2,029.6 124.3 122.4
Stockholders' Equity 4,318.6 4,093.8 3,737.0 3,085.7 3,965.2 3,659.7 3,111.0 2,757.4 2,713.1 1,877.3 (72.8) (92.9)
Cash Flow
Operating Cash Flow 1,355.8 1,395.9 1,092.0 1,272.0 778.5 899.6 776.4 798.9 693.1 590.5 (52.2)
Capital Expenditure (58.8) (48.1) (24.0) (498.2) (45.5) (379.3) (182.3) (131.5) (114.0) (181.6) (1.4)
Free Cash Flow 1,297.0 1,347.8 1,068.0 773.8 733.0 520.4 594.1 667.4 579.1 409.0 (53.6)